Total Positions
80
Quarter
2025 Q4
Top Holding
KLAC (15.6%)
Top 10 Concentration
54.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 80
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KLAC
KLA CORPORATION
|
Technology | 15.57% | 17.82% |
#1
Prev: #1
|
6.2 | no change | no change |
P
S
|
21,883 | $26,589,596 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 9.56% | 10.79% |
#2
Prev: #2
|
3.8 | -14,000 | -4.4% |
P
S
|
302,842 | $16,335,297 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 5.01% | 2.31% |
#3
8
Prev: #11
|
4.3 | 720,000 | 82.5% |
P
S
|
1,592,938 | $8,554,077 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 4.83% | 3.73% |
#4
1
Prev: #5
|
4.0 | 50,000 | 23.8% |
P
S
|
260,000 | $8,252,400 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LRCX
LAM RESEARCH CO...
|
Technology | 4.04% | — |
#5
Prev: #—
|
3.6 | 40,329 | no change |
NEW
|
40,329 | $6,903,518 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 3.94% | 1.29% |
#6
16
Prev: #22
|
3.7 | 95,000 | 54.6% |
P
S
|
269,000 | $6,725,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 3.66% | 1.65% |
#7
7
Prev: #14
|
3.5 | 12,000 | 15.4% |
P
S
|
90,000 | $6,259,500 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 2.81% | 2.41% |
#8
2
Prev: #10
|
3.2 | 7,000 | 14.6% |
P
S
|
55,000 | $4,803,700 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 2.67% | 2.76% |
#9
Prev: #9
|
1.1 | no change | no change |
P
S
|
171,000 | $4,567,410 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OVV
OVINTIV INC
|
Energy | 2.47% | 3.28% |
#10
3
Prev: #7
|
1.0 | no change | no change |
P
S
|
107,500 | $4,212,925 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRTA
PROTHENA CORP P...
|
Healthcare | 2.47% | 4.05% |
#11
7
Prev: #4
|
1.0 | -108,000 | -19.7% |
P
S
|
441,019 | $4,211,731 | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 2.33% | 1.38% |
#12
9
Prev: #21
|
3.2 | 409,000 | 137.7% |
P
S
|
705,955 | $3,981,586 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.26% | 3.04% |
#13
5
Prev: #8
|
0.9 | -1,500 | -5.2% |
P
S
|
27,190 | $3,856,358 | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 2.11% | 1.51% |
#14
4
Prev: #18
|
0.8 | no change | no change |
P
S
|
253,000 | $3,602,720 | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCYC
BICYCLE THERAPE...
|
Healthcare | 1.92% | 0.90% |
#15
15
Prev: #30
|
3.1 | 308,700 | 200.5% |
P
S
|
462,700 | $3,275,916 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 1.89% | 0.76% |
#16
22
Prev: #38
|
3.1 | 110,000 | 129.4% |
P
S
|
195,000 | $3,235,050 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CSTL
CASTLE BIOSCIEN...
|
Healthcare | 1.84% | 1.90% |
#17
4
Prev: #13
|
0.8 | -30,000 | -27.1% |
P
S
|
80,600 | $3,135,340 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 1.66% | 0.78% |
#18
18
Prev: #36
|
3.0 | 255,400 | 425.7% |
P
S
|
315,400 | $2,835,446 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 1.63% | 0.93% |
#19
9
Prev: #28
|
2.7 | 25,000 | 23.8% |
P
S
|
130,000 | $2,792,400 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 1.37% | 4.22% |
#20
17
Prev: #3
|
0.5 | no change | no change |
P
S
|
67,200 | $2,338,560 | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.30% | — |
#21
Prev: #—
|
2.5 | 44,000 | no change |
NEW
|
44,000 | $2,228,160 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QDEL
QUIDELORTHO COR...
|
Healthcare | 1.21% | 1.61% |
#22
6
Prev: #16
|
0.5 | no change | no change |
P
S
|
72,548 | $2,071,971 | 2014 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVCR
NOVOCURE LTD
|
Healthcare | 1.15% | 1.00% |
#23
3
Prev: #26
|
2.6 | 50,000 | 49.0% |
P
S
|
152,100 | $1,966,653 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDSX
BIODESIX INC
|
Healthcare | 1.14% | 1.63% |
#24
9
Prev: #15
|
0.5 | no change | no change |
P
S
|
286,804 | $1,950,267 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.12% | 1.24% |
#25
2
Prev: #23
|
0.4 | no change | no change |
P
S
|
30,000 | $1,906,200 | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.00% | 1.60% |
Sold All 😨
(Was: #17) |
0.3 | -119,078 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
KINIKSA PHARMAC...
|
—
|
Unknown | 0.00% | 0.88% |
Sold All 😨
(Was: #32) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
SRRK
SCHOLAR ROCK HO...
|
Healthcare | 0.00% | 0.73% |
Sold All 😨
(Was: #39) |
0.3 | -26,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 0.30% |
Sold All 😨
(Was: #52) |
0.3 | -31,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 0.00% | 0.28% |
Sold All 😨
(Was: #53) |
0.3 | -6,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.00% | 0.28% |
Sold All 😨
(Was: #55) |
0.3 | -16,500 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 0.00% | 0.22% |
Sold All 😨
(Was: #60) |
0.3 | -16,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TELA
TELA BIO INC
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #61) |
0.3 | -155,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XLV
HEALTHCARE SELE...
|
Unknown | 0.00% | 0.16% |
Sold All 😨
(Was: #63) |
0.3 | -1,498 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.00% | 0.14% |
Sold All 😨
(Was: #64) |
0.3 | -27,985 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLT
APPLIED THERAPE...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #65) |
0.3 | -225,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IFRX
INFLARX NV
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #67) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 80 holdings